image
Summit Therapeutics Inc. SMMT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 27.35
2.48 %
$ 20.2 B
Market Cap
-81.35
P/E
Price Target Average
20.66%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--493.13%
Net Income Estimate
47.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Summit Therapeutics Inc.
image
Wall Street analysts predict an average 1-year price target for SMMT of $33 , with forecasts ranging from a low of $14 to a high of $45 .
SMMT Lowest Price Target Wall Street Target
14 USD -48.81%
SMMT Average Price Target Wall Street Target
33 USD 20.66%
SMMT Highest Price Target Wall Street Target
45 USD 64.53%
Price
Max Price Target
Min Price Target
Average Price Target
454540403535303025252020151510105500Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart SMMT

image
$2.0b$2.0b$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.02015201520162016201720172018201820192019202020202021202120232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart SMMT

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)2015201520162016201720172018201820192019202020202021202120232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart SMMT

image
$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)2015201520162016201720172018201820192019202020202021202120232023202420242025202520262026202720272028202820292029